Richard C. Chao
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 29
- Pancreatic and Hepatic Oncology Research 23
- Lung Cancer Research Studies 21
- Peptidase Inhibition and Analysis 10
- Neurology top 1%
- Neuroblastoma Research and Treatments 7
- Epidemiology top 1%
- Neuroendocrine Tumor Research Advances 15
-
- Lung Cancer Treatments and Mutations 48
- Gastric Cancer Management and Outcomes 8
- Cancer Research top 5%
- Co-authors
- Juan W. ValleJean‐Luc RaoulShem PatynaYung‐Jue BangÉric RaymondIvan BorbathPeter MetrakosCatherine Lombard‐Bohas
- Cited by
- OncologyNeurologyEpidemiology
- Journals
- New England Journal of Medicine (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (32 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Richard C. Chao
87 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 2.9k
- Neurology 1.2k
- Epidemiology 1.7k
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 421
Countries citing papers authored by Richard C. Chao
This map shows the geographic impact of Richard C. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Chao more than expected).
Fields of papers citing papers by Richard C. Chao
This network shows the impact of papers produced by Richard C. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Chao. The network helps show where Richard C. Chao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Richard C. Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 37 | |
| 3 | 2023 | 13 | |
| 4 | 2022 | 4 | |
| 5 | 2013 | 3 | |
| 6 | 2013 | 47 | |
| 7 | Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET) | 2012 | 4 |
| 8 | 2012 | 22 | |
| 9 | 2012 | 34 | |
| 10 | 2011 | 24 | |
| 11 | Evaluation of Progression-Free Survival by Blinded Independent Central Review in Patients With Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors Treated With Sunitinib or Placebo | 2011 | 2 |
| 12 | Overall Survival (OS) Analysis of Sunitinib (SU) after Adjustment for Crossover (CO) in Patients with Pancreatic Neuroendocrine Tumors (NET) | 2011 | 1 |
| 13 | 2011 | 41 | |
| 14 | 2011 | 11 | |
| 15 | Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial | 2010 | 1 |
| 16 | 2010 | 38 | |
| 17 | 2008 | 1 | |
| 18 | 2007 | 5 | |
| 19 | 2005 | 33 | |
| 20 | 1995 | 39 |
About Richard C. Chao
Richard C. Chao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 90 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (48 papers), Colorectal Cancer Treatments and Studies (29 papers), Pancreatic and Hepatic Oncology Research (23 papers), Lung Cancer Research Studies (21 papers), Neuroendocrine Tumor Research Advances (15 papers), Peptidase Inhibition and Analysis (10 papers), Gastric Cancer Management and Outcomes (8 papers) and Neuroblastoma Research and Treatments (7 papers). The work is most often cited by research in Oncology (2.9k citations), Neurology (1.2k citations) and Epidemiology (1.7k citations). Richard C. Chao has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Juan W. Valle, Jean‐Luc Raoul, Shem Patyna, Yung‐Jue Bang, Éric Raymond, Ivan Borbath, Peter Metrakos, Catherine Lombard‐Bohas, Dieter Hörsch and Aaron I. Vinik. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.